Author:
Tashima Rumiko,Nishimura Reiki
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Inaji H, Komoike Y, Motomura K et al (2002) The role of neoadjuvant chemotherapy for breast cancer treatment. Jpn J Cancer Chemother 29:1113–1119
2. Bernard F, John B, Norman W et al (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672–2685
3. Nishimura R, Nagao K, Miyayama H et al (2002) An evaluation of predictive factors involved in clinical or pathological response to primary chemotherapy in advanced breast cancer. Breast Cancer l9:145–152
4. Hirano A, Shimizu T, Imamura H et al (2006) The combination of Epirubicin plus Docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer. Anticancer Res 26:581–584
5. Steger GG, Galid A, Gunat M (2007) ABCSG-14: Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granlocyte colony — stimulating factor in operable breast cancer: results of ABCSG-14: J Clin Oncol 25:2012–2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献